Add-on Acquisition • Life Science

Lyell Acquires ImmPACT Bio

On October 24, 2024, Lyell acquired life science company ImmPACT Bio

Acquisition Context

This is Lyell’s 1st transaction in the Life Science sector.
This is Lyell’s 1st transaction in the United States.
This is Lyell’s 1st transaction in California.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	October 24, 2024
Target	ImmPACT Bio
Sector	Life Science
Buyer(s)	Lyell
Deal Type	Add-on Acquisition
Advisor(s)	Cooley (Legal)

Target Company

ImmPACT Bio

West Hills, California, United States

ImmPACT Bio is a clinical-stage biotechnology company. ImmPACT’s lead program, IMPT-314, is a CD19/20-targeting chimeric antigen receptor (CAR) T-cell product candidate Lyell will continue developing for hematologic malignancies, including large B-cell lymphoma. IMPT-314 was designed to outperform the efficacy of approved CD19 CAR T-cell therapies via a dual-targeting CAR T-cell design and to improve CAR T-cell persistence by enriching for naïve and central memory T cells during manufacturing. ImmPACT Bio was founded in 2017 and is based in West Hills, California.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Lyell

South San Francisco, California, United States

Category	Company
Founded	2018
Sector	Life Science
Employees	224
Revenue	85M USD (2022)

DESCRIPTION

Lyell is a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies. Lyell’s product candidates are enhanced with novel technology designed to generate T cells that resist exhaustion and have qualities of durable stemness in order to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical response. Lyell was founded in 2018 and is based in South San Francisco, California.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: California	1 of 1
Country: United States	1 of 1
Year: 2024	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 2024 M&A